MedTrace Logo

Biomarker Feedback to Motivate Cessation in Pregnancy

NCT02431611 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-12-19

No results posted yet for this study

Summary

Phase 3 Pilot Clinical Trial.

Conditions

  • Nicotine Dependence
  • Pregnancy

Interventions

BEHAVIORAL

Biomarker feedback (phone based smoking cessation counseling)

Feedback on maternal cotinine and likely infant NNAL Phone based behavioral smoking cessation counseling

BEHAVIORAL

Control condition (phone based smoking cessation counseling)

phone-based behavioral smoking cessation counseling

Sponsors & Collaborators

Principal Investigators

  • Christi A Patten, PhD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02431611 on ClinicalTrials.gov